Connection
Michael Rizzari to Hepacivirus
This is a "connection" page, showing publications Michael Rizzari has written about Hepacivirus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.075 |
|
|
|
-
Shimada S, Ivanics T, Kitajima T, Shamaa T, Rizzari M, Collins K, Yoshida A, Abouljoud M, Moonka D, Zhang J, Lu M, Nagai S. Improvements in liver transplant outcomes in patients with HCV/HIV coinfection after the introduction of direct-acting antiviral therapies. Transpl Infect Dis. 2022 Apr; 24(2):e13808.
Score: 0.039
-
Ivanics T, Rizzari M, Moonka D, Al-Kurd A, Delvecchio K, Kitajima T, Elsabbagh AM, Collins K, Yoshida A, Abouljoud M, Nagai S. Retransplantation outcomes for hepatitis C in the United States before and after direct-acting antiviral introduction. Am J Transplant. 2021 03; 21(3):1100-1112.
Score: 0.036